Alzamend Neuro regains Nasdaq compliance
- Alzamend Neuro (ALZN) received a notification letter from Nasdaq dated September 14, 2026, informing Alzamend that it has regained compliance.
- In the compliance notice, Nasdaq stated that Alzamend complies with the equity rule and the matter is now closed.
More on Alzamend Neuro
KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.